David Ternant

Withdrawal of Immunosuppression in Crohn's Disease Treated With Scheduled Infliximab Maintenance: A Randomized Trial

Gert Van Assche, Charlotte Magdelaine–Beuzelin, Geert D’Haens et al. · Gastroenterology · 2008 · 494 citations · Full text

Inflammation, Disease Treated, Autoimmune Disease +9

Bevacizumab in Patients With Hereditary Hemorrhagic Telangiectasia and Severe Hepatic Vascular Malformations and High Cardiac Output

Sophie Dupuis‐Girod, Isabelle Ginon, Jean‐Christophe Saurin et al. · JAMA · 2012 · 378 citations

Infliximab Pharmacokinetics in Inflammatory Bowel Disease Patients

David Ternant, Alexandre Aubourg, Charlotte Magdelaine–Beuzelin et al. · Therapeutic Drug Monitoring · 2008 · 181 citations

Immunology, Gastroenterology, Pharmacotherapy +16

Behavior and serotonergic disorders in rats exposed prenatally to valproate: A model for autism

Diane Dufour‐Rainfray, Patrick Vourc’h, Anne‐Marie Le Guisquet et al. · Neuroscience Letters · 2009 · 165 citations

Psychiatry, Behavioral Neuroscience, Serotonergic Disorders +12

Antibodies toward infliximab are associated with low infliximab concentration at treatment initiation and poor infliximab maintenance in rheumatic diseases

Émilie Ducourau, Denis Mulleman, Gilles Paintaud et al. · Arthritis Research & Therapy · 2011 · 158 citations · Full text